NASDAQ:KPTI

Karyopharm Therapeutics Stock News

etoro logo Buy KPTI
*Your capital is at risk
$9.00
-0.230 (-2.49%)
At Close: Jun 03, 2026
Karyopharm Therapeutics (KPTI) delivered earnings and revenue surprises of -26.47% and 0.87%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the st

Karyopharm: Recent Sell-Off Hits A New Buy Target

09:37pm, Wednesday, 28'th Dec 2022
Karyopharm is still reporting growth, but the market continues to punish KPTI to fresh 52-week lows. I take a look at the company's Q3 earnings report. XPOVIO delivered strong year-over-year growth wi
Upgrades Citigroup upgraded the previous rating for Advanced Energy Industries Inc (NASDAQ:AEIS) from Neutral to Buy. For the third quarter, Advanced Energy Indus had an EPS of $2.12, compared to yea
Telsey Advisory Group raised Under Armour, Inc.. (NASDAQ: UAA) price target from $8 to $9. Telsey Advisory Group analyst Cristina Fernandez maintained the stock with a Market Perform rating. Under A

Karyopharm Therapeutics (KPTI) Q3 2022 Earnings Call Transcript

04:00am, Friday, 04'th Nov 2022 The Motley Fool
KPTI earnings call for the period ending September 30, 2022.
Karyopharm Therapeutics Inc. (NASDAQ:KPTI ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Elhan Webb - Senior Vice President-Investor Relations Richard Paulson - Pr
Karyopharm Therapeutics (KPTI) delivered earnings and revenue surprises of 19.64% and 3.82%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the st

Aziyo Biologics, Inc. (AZYO) Soars 11.7%: Is Further Upside Left in the Stock?

01:47pm, Tuesday, 25'th Oct 2022 Zacks Investment Research
Aziyo Biologics, Inc. (AZYO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further pric

Karyopharm: Market Is Overlooking Growth

12:07pm, Friday, 07'th Oct 2022
Karyopharm's growth strategy has generated significant increases in total revenues, net product revenue growth, licensing revenue, and milestone revenue. Despite the progress, the market continues to
U.S. stocks closed mixed with the Dow Jones dropping around 125 points on Tuesday. Here is the list of some big stocks recording gains in the previous session. Grove Collaborative Holdings, Inc. (NY

Expert Ratings for Karyopharm Therapeutics

04:24pm, Friday, 09'th Sep 2022 Benzinga
Analysts have provided the following ratings for Karyopharm Therapeutics (NASDAQ:KPTI) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 2

Where Karyopharm Therapeutics Stands With Analysts

01:30pm, Friday, 09'th Sep 2022 Benzinga
Karyopharm Therapeutics (NASDAQ:KPTI) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 2 1 0 0
Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) surged 13.5% to $19.25 in pre-market trading. A consortium led by Hollysys Automation’s management is looking to take the US-listed company priva
Gainers NewAge, Inc. (NASDAQ: NBEV) shares rose 58.3% to $0.1935 in pre-market trading. NewAge shares tumbled around 47% on Thursday on continued weakness after the company recently announced it file

Best Penny Stocks To Buy: 4 Short Squeeze Stocks To Watch Now

05:29pm, Monday, 08'th Aug 2022 PennyStocks
Penny stocks to buy: Here's what short interest traders think The post Best Penny Stocks To Buy: 4 Short Squeeze Stocks To Watch Now appeared first on Penny Stocks to Buy, Picks, News and Information
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE